Category stocks

Calidi Biotherapeutics Posts Q1 Loss

Calidi Biotherapeutics reports Q1 GAAP EPS of -$0.43 Calidi Biotherapeutics reported a Q1 GAAP EPS of -$0.43. The company's cash position as of March 31, 2026, was $6.6 million, with an additional $0.2 million in restricted cash. This compares to $5.6 million in